Scalper1 News
Prescription drug stocks have held up well despite the market’s correction as quarterly earnings loom. The 40-member Medical-Ethical Drugs group climbed 66% last year, more than double the S&P 500’s 30% gain. The group is up an additional 12% so far this year and is just 1% off a record high. So it’s no surprise that the group on Wednesday ranked third out of the 197 industries tracked by IBD, up from No. 9 six weeks ago. Four stocks in the Scalper1 News
Scalper1 News